Our platform is already used worldwide by
thought-leading partners…
Our platform is already used worldwide by
thought-leading partners…
… in hundreds of hospitals with thousands of patients.
Epilepsy
400+ healthcare professionals
13.000+ patients
Chronic Pain
R&D Phase
Multiple Sclerosis
R&D Phase
Headache
100+ healthcare professionals
10.000+ patients
Stroke
R&D Phase
Parkinson’s Disease
R&D Phase
… in hundreds of hospitals with thousands of patients.
Epilepsy
400+ healthcare professionals
13.000+ patients
Headache
100+ healthcare professionals
10.000+ patients
Multiple Sclerosis
R&D Phase
Parkinson’s Disease
R&D Phase
Chronic Pain
R&D Phase
Stroke
R&D Phase
Integrated offering to maximize engagement and
minimize friction across the study
Study participants
Study participants use our mobile applications (or lower-level technologies) to onboard your study, capture endpoints at the right time (self-reported or via devices) and stay engaged during the study.
Customizable mobile app to collect ePRO / eCOA / eDiary with a focus on simplicity to maximize compliance in a heterogeneous population.
Participants can seamlessly continue using the app beyond the trial, with their doctor, to improve their care management.
With our experience in clinical practice, as well as clinical trials, we roll out engagement features to maximize data quality.
Study sites
Study sites are supported throughout the study to easily recruit patients, real-time monitor their patients, and seamlessly spot low-compliant patients.
Our platform is focused on making sites efficient when recruiting participants, as well as when following up on them, to maximize site engagement and compliance.
Sites can continue using the platform for their own practice, with the study participants, as well as others.
Sponsor CRO
Sponsors (or CRO’s, academic centers) can perform real-time site monitoring through our sponsor dashboard.
Our platform is built to efficiently tailor it to your needs for your specific trial.
The platform allows us to keep on top of the study progress and act where needed.
We have integrated the Neuroventis Platform with several study databases (custom, CDISC standards…) to automate data collection, reducing time and error rates.
Our platform allows us to easily integrate data from devices (e.g. NightWatch seizure detection) or add compliance tools (e.g. connected pillboxes).
Integrated offering to maximize engagement and minimize friction across the study
Study participants
Study participants use our mobile applications (or lower-level technologies) to onboard your study, capture endpoints at the right time (self-reported or via devices) and stay engaged during the study.
Customizable mobile app to collect ePRO / eCOA / eDiary with a focus on simplicity to maximize compliance in a heterogeneous population.
Participants can seamlessly continue using the app beyond the trial, with their doctor, to improve their care management.
With our experience in clinical practice, as well as clinical trials, we roll out engagement features to maximize data quality.
Study sites
Study sites are supported throughout the study to easily recruit patients, real-time monitor their patients, and seamlessly spot low-compliant patients.
Our platform is focused on making sites efficient when recruiting participants, as well as when following up on them, to maximize site engagement and compliance.
Sites can continue using the platform for their own practice, with the study participants, as well as others.
Sponsor CRO
Sponsors (or CRO’s, academic centers) can perform real-time site monitoring through our sponsor dashboard.
Our platform is built to efficiently tailor it to your needs for your specific trial.
The platform allows us to keep on top of the study progress and act where needed.
We have integrated the Neuroventis Platform with several study databases (custom, CDISC standards…) to automate data collection, reducing time and error rates.
Our platform allows us to easily integrate data from devices (e.g. NightWatch seizure detection) or add compliance tools (e.g. connected pillboxes).
Our offering can make your
research more efficient and
more reliable
Our platform is pathology-specific, customizable to your study needs, with an extremely short startup time
Already 10+ epilepsy and headache trials customized, with implementation times of days to weeks, depending on the customer’s processes & complexity. The major PROs in epilepsy and headache are already configured, configuring a new one takes only hours.
Patients and sites stay
engaged
With our user-friendly tool and our engagement features, we maximize data collection, data quality, and compliance.
Real-time overview of study progress
As a trial manager, you spot issues faster. Your team and sites also receive the right toolkit to comply with your protocol.
Integrated with existing workflows and tools
We have integrated with several study databases (e.g. Medidata Rave) using CDISC standards or sponsor-specific standard. We have also devices integrated to our platform to increase innovation in your trial (e.g. seizure detection device NightWatch from LivAssured).
Experienced and dedicated team to support your study
Our team has very focused experience on epilepsy and headache trials, working with epilepsy/headache centers, CRO’s and sponsors.
Regulatory compliance for easy ethics commission approvals
Our tool has been included successfully in ethical committee approvals across the whole world, from the US to South Korea, and all major countries in Europe (UK, DE, FR, IT, ES, DK, NL, BE, PO, BG, RO…).
Smooth transition to real-world data capturing after the study
After the trial, study participants and investigators can continue using the Neuroventis Platform in daily clinical practice effortlessly, paving the way to real-world evidence or open-label extensions.
Unique access to patients for recruitment
With our existing user base, you can reach out to shorten recruitment times and bring highly-qualified patients to your study sites.
Our offering can make your research more efficient and more reliable
Our platform is pathology-specific, customizable to your study needs, with an extremely short startup time
Already 10+ epilepsy and headache trials customized, with implementation times of days to weeks, depending on the customer’s processes & complexity. The major PROs in epilepsy and headache are already configured, configuring a new one takes only hours.
Patients and sites stay
engaged
With our user-friendly tool and our engagement features, we maximize data collection, data quality, and compliance.
Real-time overview of study progress
As a trial manager, you spot issues faster. Your team and sites also receive the right toolkit to comply with your protocol.
Integrated with existing workflows and tools
We have integrated with several study databases (e.g. Medidata Rave) using CDISC standards or sponsor-specific standard. We have also devices integrated to our platform to increase innovation in your trial (e.g. seizure detection device NightWatch from LivAssured).
Experienced and dedicated team to support your study
Our team has very focused experience on epilepsy and headache trials, working with epilepsy/headache centers, CRO’s and sponsors.
Regulatory compliance for easy ethics commission approvals
Our tool has been included successfully in ethical committee approvals across the whole world, from the US to South Korea, and all major countries in Europe (UK, DE, FR, IT, ES, DK, NL, BE, PO, BG, RO…).
Smooth transition to real-world data capturing after the study
After the trial, study participants and investigators can continue using the Neuroventis Platform in daily clinical practice effortlessly, paving the way to real-world evidence or open-label extensions.
Unique access to patients for recruitment
With our existing user base, you can reach out to shorten recruitment times and bring highly-qualified patients to your study sites.
Use cases: Our partners and we publish about
our platform use in research
Use cases: Our partners and we publish about
our platform use in research
Featured use-case: Phase 4 study of UCB
across 5 countries and 81 sites
Study:
A 12-Month Non-interventional Observational Multinational Study to Evaluate Effectiveness, Tolerability, and Quality of Life of Brivaracetam Adjunctive Therapy in Earlier Treatment Lines in Adult Patients with History of Partial-Onset Seizures in Daily Clinical Practice
Study phase:
Phase 4
409 participants,
81 sites:
(5 countries, North America + Europe)
Sponsor:
UCB Pharma; CRO: Parexel;
EDC System: Medidata Rave
Featured use-case: Phase 4 study of UCB across 5 countries and 81 sites
Study:
A 12-Month Non-interventional Observational Multinational Study to Evaluate Effectiveness, Tolerability, and Quality of Life of Brivaracetam Adjunctive Therapy in Earlier Treatment Lines in Adult Patients with History of Partial-Onset Seizures in Daily Clinical Practice
Study phase:
Phase 4
409 participants,
81 sites:
(5 countries, North America + Europe)
Sponsor:
UCB Pharma; CRO: Parexel;
EDC System: Medidata Rave
Our medical device software is meeting
EU and US quality and regulatory compliance
CE Marked
EU MDD Class I,
transition EU
MDR Class I
FDA registered
21 CFR Part 820
21 CFR Part 11
Certifications & Audits
Audited and approved supplier
to major pharma companies
and hospitals
Certified
ISO13485:2016 Quality Management
System for Medical Devices
ISO27001:2013 Information
Security management
System
Part of SOPs
ISO14155:2020
IEC62304 Software Life Cycle
ISO14971 Risk management
Security & Privacy
GDPR compliance
HIPAA compliance
PIPAA (South Korea)
Regulatory team to expand
to other regions
Regular penetration tests
under OWASP ASVS Checklist
Our medical device software is meeting EU and US quality and regulatory compliance
CE Marked
EU MDD Class I,
transition EU
MDR Class I
FDA registered
21 CFR Part 820
21 CFR Part 11
Certifications & Audits
Audited and approved supplier
to major pharma companies
and hospitals
Certified
ISO13485:2016 Quality Management
System for Medical Devices
ISO27001:2013 Information
Security management
System
Part of SOPs
ISO14155:2020
IEC62304 Software Life Cycle
ISO14971 Risk management
Security & Privacy
GDPR compliance
HIPAA compliance
PIPAA (South Korea)
Regulatory team to expand
to other regions
Regular penetration tests
under OWASP ASVS Checklist
Interest in knowing more?
Feel free to contact us via this form, and we will
come back to you as soon as possible.
Interest in knowing more?
Feel free to contact us via this form, and we will come back to you as soon as possible.
Request demo